Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Azd9668
2. N-((5-(methanesulfonyl)pyridin-2-yl)methyl)-6-methyl-5-(1-methyl-1h-pyrazol-5-yl)-2-oxo-1-(3-(trifluoromethyl)phenyl)-1,2-dihydropyridine-3-carboxamide
1. 848141-11-7
2. Alvelestat (azd9668)
3. Alvelestat [inn]
4. Alvelestat; Azd 9668
5. Avelestat-azd9668
6. Azd 9668
7. Azd-9668
8. Azd9668
9. Azd9668;azd-9668;azd 9668
10. Alvelestat (azd9688)
11. Mph966
12. Chembl3617964
13. Mph-966
14. 6-methyl-5-(1-methyl-1h-pyrazol-5-yl)-n-((5-(methylsulfonyl)pyridin-2-yl)methyl)-2-oxo-1-(3-(trifluoromethyl)phenyl)-1,2-dihydropyridine-3-carboxamide
15. N-((5-(methanesulfonyl)pyridin-2-yl)methyl)-6-methyl-5-(1-methyl-1h-pyrazol-5-yl)-2-oxo-1-(3-(trifluoromethyl)phenyl)-1,2-dihydropyridine-3-carboxamide
16. 6y5629322x
17. 6-methyl-5-(2-methylpyrazol-3-yl)-n-[(5-methylsulfonylpyridin-2-yl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide
18. Avelestat
19. 3-pyridinecarboxamide, 1,2-dihydro-6-methyl-5-(1-methyl-1h-pyrazol-5-yl)-n-[[5-(methylsulfonyl)-2-pyridinyl]methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]-
20. Unii-6y5629322x
21. 3-pyridinecarboxamide, 1,2-dihydro-6-methyl-5-(1-methyl-1h-pyrazol-5-yl)-n-((5-(methylsulfonyl)-2-pyridinyl)methyl)-2-oxo-1-(3-(trifluoromethyl)phenyl)-
22. 6-methyl-5-(1-methyl-1h-pyrazol-5-yl)-n-((5-(methylsulfonyl)pyridin-2-yl)methyl)-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2-dihydropyridine-3-carboxamide
23. 6-methyl-5-(1-methyl-1h-pyrazol-5-yl)-n-{[5-(methylsulfonyl)pyridin-2-yl]methyl}-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2-dihydropyridine-3-carboxamide
24. N-{[5-(methanesulfonyl)pyridin-2-yl]methyl}-6-methyl-5-(1-methyl-1h-pyrazol-5-yl)-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2-dihydropyridine-3-carboxamide
25. Alvelestat [who-dd]
26. Schembl560757
27. Gtpl6476
28. Dtxsid40233875
29. Bcp07945
30. Ex-a2004
31. Alvelestat (azd848141-11-7
32. Bdbm50120430
33. Zinc72316197
34. Cs-1684
35. Db11863
36. Sb19590
37. Ncgc00378593-01
38. Ncgc00378593-04
39. Ncgc00378593-05
40. Ncgc00378593-07
41. Ncgc00378593-08
42. Ac-32671
43. As-56012
44. Da-35310
45. Hy-15651
46. Kb-105160
47. Ft-0722953
48. C76706
49. Q27074417
50. N-[(5-methanesulfonylpyridin-2-yl)methyl]-6-methyl-5-(1-methyl-1h-pyrazol-5-yl)-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2-dihydropyridine-3-carboxamide
| Molecular Weight | 545.5 g/mol |
|---|---|
| Molecular Formula | C25H22F3N5O4S |
| XLogP3 | 2.5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 6 |
| Exact Mass | 545.13445986 g/mol |
| Monoisotopic Mass | 545.13445986 g/mol |
| Topological Polar Surface Area | 123 Ų |
| Heavy Atom Count | 38 |
| Formal Charge | 0 |
| Complexity | 1100 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Alvelestat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Alvelestat, including repackagers and relabelers. The FDA regulates Alvelestat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Alvelestat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Alvelestat supplier is an individual or a company that provides Alvelestat active pharmaceutical ingredient (API) or Alvelestat finished formulations upon request. The Alvelestat suppliers may include Alvelestat API manufacturers, exporters, distributors and traders.
Alvelestat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Alvelestat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Alvelestat GMP manufacturer or Alvelestat GMP API supplier for your needs.
A Alvelestat CoA (Certificate of Analysis) is a formal document that attests to Alvelestat's compliance with Alvelestat specifications and serves as a tool for batch-level quality control.
Alvelestat CoA mostly includes findings from lab analyses of a specific batch. For each Alvelestat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Alvelestat may be tested according to a variety of international standards, such as European Pharmacopoeia (Alvelestat EP), Alvelestat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Alvelestat USP).
LOOKING FOR A SUPPLIER?
